$MOTS
Motus GI Holdings Inc Stock $mots

$mots Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222032096 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$109.0K	$278.0K	$141.0K
YoY Change	10.1%	97.16%	370.0%
Cost Of Revenue	$471.0K	$83.00K	$65.00K
YoY Change	923.91%	27.69%	116.67%
Gross Profit	-$362.0K	$195.0K	$76.00K
YoY Change	-783.02%	156.58%
Gross Profit Margin	-332.11%	70.14%	53.9%
Selling, General & Admin	$2.315M	$3.327M	$3.040M
YoY Change	-24.1%	9.44%	14.29%
% of Gross Profit		1706.15%	4000.0%
Research & Development	$1.350M	$1.573M	$1.187M
YoY Change	3.77%	32.52%	2.33%
% of Gross Profit		806.67%	1561.84%
Depreciation & Amortization	$129.0K	$128.0K	$118.0K
YoY Change	6.61%	8.47%	47.5%
% of Gross Profit		65.64%	155.26%
Operating Expenses	$3.665M	$4.900M	$4.227M
YoY Change	-15.77%	15.92%	10.37%
Operating Profit	-$4.027M	-$4.705M	-$4.151M
YoY Change	-6.31%	13.35%	8.38%
Interest Expense	$345.0K	$338.0K	-$255.0K
YoY Change	-231.18%	-232.55%	112.5%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00	$5.000K
YoY Change		-100.0%
Pretax Income	-$3.682M	-$4.964M	-$4.824M
YoY Change	-23.58%	2.9%	22.44%
Income Tax
% Of Pretax Income
Net Earnings	-$3.682M	-$4.964M	-$4.824M
YoY Change	-23.58%	2.9%	22.44%
Net Earnings / Revenue	-3377.98%	-1785.61%	-3421.28%
Basic Earnings Per Share		-$1.69	-$2.00
Diluted Earnings Per Share	-$0.79	-$1.690M	-$2.000M
COMMON SHARES
Basic Shares Outstanding	4.656M shares	2.997M shares
Diluted Shares Outstanding		183.9K shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.04M	$13.29M	$23.65M
YoY Change	-37.77%	-43.79%	-0.16%
Cash & Equivalents	$14.00M	$13.29M	$23.65M
Short-Term Investments
Other Short-Term Assets	$781.0K	$1.018M	$530.0K
YoY Change	-1.51%	92.08%	-40.45%
Inventory	$999.0K	$1.014M	$515.0K
Prepaid Expenses
Receivables	$59.00K	$161.0K	$181.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$15.37M	$15.49M	$24.88M
YoY Change	-35.85%	-37.75%	-3.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.325M	$1.395M	$2.187M
YoY Change	-7.21%	-36.21%	20.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.00K	$13.00K	$13.00K
YoY Change	0.0%	0.0%	30.0%
Total Long-Term Assets	$2.277M	$1.879M	$2.200M
YoY Change	7.0%	-14.59%	20.22%
TOTAL ASSETS
Total Short-Term Assets	$15.37M	$15.49M	$24.88M
Total Long-Term Assets	$2.277M	$1.879M	$2.200M
Total Assets	$17.65M	$17.37M	$27.08M
YoY Change	-32.36%	-35.87%	-2.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.969M	$2.696M	$2.337M
YoY Change	-23.8%	15.36%	23.65%
Accrued Expenses	$245.0K	$248.0K	$300.0K
YoY Change	-20.2%	-17.33%	25.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.532M	$2.453M
YoY Change	487.47%
Total Short-Term Liabilities	$4.799M	$5.467M	$2.646M
YoY Change	44.03%	106.61%	-74.85%
LONG-TERM LIABILITIES
Long-Term Debt	$4.589M	$5.251M	$8.426M
YoY Change	-35.56%	-37.68%
Other Long-Term Liabilities	$1.390M	$2.009M	$2.226M
YoY Change	-35.2%	-9.75%	0.27%
Total Long-Term Liabilities	$4.589M	$5.251M	$10.65M
YoY Change	-35.56%	-50.7%	379.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.799M	$5.467M	$2.646M
Total Long-Term Liabilities	$4.589M	$5.251M	$10.65M
Total Liabilities	$14.67M	$16.60M	$13.30M
YoY Change	-10.72%	24.86%	4.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$141.4M	-$137.7M
YoY Change	15.19%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.977M	$762.0K	$13.78M
YoY Change
Total Liabilities & Shareholders Equity	$17.65M	$17.37M	$27.08M
YoY Change	-32.36%	-35.87%	-2.39%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$3.682M	-$4.964M	-$4.824M
YoY Change	-23.58%	2.9%	22.44%
Depreciation, Depletion And Amortization	$129.0K	$128.0K	$118.0K
YoY Change	6.61%	8.47%	47.5%
Cash From Operating Activities	-$4.038M	-$3.618M	-$2.910M
YoY Change	3.09%	24.33%	9.4%
INVESTING ACTIVITIES
Capital Expenditures	$9.000K	-$166.0K	-$156.0K
YoY Change	-120.0%	6.41%	1460.0%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	-$9.000K	-$166.0K	-$156.0K
YoY Change	-80.0%	6.41%	1460.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.795M	1.321M	339.0K
YoY Change	66.9%	289.68%	-96.33%
NET CHANGE
Cash From Operating Activities	-4.038M	-3.618M	-2.910M
Cash From Investing Activities	-9.000K	-166.0K	-156.0K
Cash From Financing Activities	4.795M	1.321M	339.0K
Net Change In Cash	748.0K	-2.463M	-2.727M
YoY Change	-168.69%	-9.68%	-141.57%
FREE CASH FLOW
Cash From Operating Activities	-$4.038M	-$3.618M	-$2.910M
Capital Expenditures	$9.000K	-$166.0K	-$156.0K
Free Cash Flow	-$4.047M	-$3.452M	-$2.754M
YoY Change	4.52%	25.34%	3.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001686850
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue		usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q3	mots	Cost Of Revenue Impairment Of Inventory CostOfRevenueImpairmentOfInventory		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2022Q3	mots	Deemed Dividends From Warrant Issuance DeemedDividendsFromWarrantIssuance		usd
CY2021Q3	mots	Deemed Dividends From Warrant Issuance DeemedDividendsFromWarrantIssuance		usd
	mots	Deemed Dividends From Warrant Issuance DeemedDividendsFromWarrantIssuance		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
	mots	Fractional Shares Paid In Cash Pursuant To Reverse Stock Split FractionalSharesPaidInCashPursuantToReverseStockSplit		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	mots	Financing Costs Included In Accounts Payable And Accrued Expenses FinancingCostsIncludedInAccountsPayableAndAccruedExpenses		usd
	mots	Warrants Issued Related To Convertible Note And Longterm Debt Recorded As Debt Discount WarrantsIssuedRelatedToConvertibleNoteAndLongtermDebtRecordedAsDebtDiscount		usd
	mots	Accrued End Of Loan Payment Recorded As Debt Discount AccruedEndOfLoanPaymentRecordedAsDebtDiscount		usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38389
	dei	Entity Registrant Name EntityRegistrantName	Motus GI Holdings, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-4042793
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1301 East Broward Boulevard
	dei	Entity Address Address Line2 EntityAddressAddressLine2	3rd Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ft. Lauderdale
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33301
	dei	City Area Code CityAreaCode	(954)
	dei	Local Phone Number LocalPhoneNumber	541 8000
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
	dei	Trading Symbol TradingSymbol	MOTS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
CY2021Q4	us-gaap	Inventory Net InventoryNet	496000	usd
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4655596	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13294000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22563000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	161000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	109000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	1014000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1018000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	793000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	15487000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	23961000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1395000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1428000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	471000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	687000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13000	usd
CY2022Q3	us-gaap	Assets Assets	17366000	usd
CY2021Q4	us-gaap	Assets Assets	26089000	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2696000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2584000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	248000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	307000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	70000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10000	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	260000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	271000	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	2453000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	431000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5467000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3332000	usd
CY2022Q3	mots	Contingent Royalty Obligation Non Current ContingentRoyaltyObligationNonCurrent	1789000	usd
CY2021Q4	mots	Contingent Royalty Obligation Non Current ContingentRoyaltyObligationNonCurrent	1760000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	220000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	385000	usd
CY2022Q3	mots	Convertible Debt Unamortized Discount Noncurrent ConvertibleDebtUnamortizedDiscountNoncurrent	123000	usd
CY2021Q4	mots	Convertible Debt Unamortized Discount Noncurrent ConvertibleDebtUnamortizedDiscountNoncurrent	166000	usd
CY2022Q3	mots	Convertible Note Noncurrent ConvertibleNoteNoncurrent	3877000	usd
CY2021Q4	mots	Convertible Note Noncurrent ConvertibleNoteNoncurrent	3834000	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	176000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	317000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5251000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7121000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	16604000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	16432000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	115000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	115000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3025502	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3025502	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2416021	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2416021	shares
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	138431000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	132411000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-137669000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-122754000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	762000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9657000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17366000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26089000	usd
CY2022Q3	us-gaap	Revenues Revenues	278000	usd
CY2021Q3	us-gaap	Revenues Revenues	141000	usd
	us-gaap	Revenues Revenues	483000	usd
	us-gaap	Revenues Revenues	292000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	83000	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	65000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	166000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	135000	usd
CY2021Q3	mots	Cost Of Revenue Impairment Of Inventory CostOfRevenueImpairmentOfInventory	186000	usd
	mots	Cost Of Revenue Impairment Of Inventory CostOfRevenueImpairmentOfInventory	159000	usd
	mots	Cost Of Revenue Impairment Of Inventory CostOfRevenueImpairmentOfInventory	186000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1573000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1187000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4261000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4040000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1349000	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	725000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3554000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2196000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1978000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2315000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6167000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7104000	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	4983000	usd
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	4478000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	14307000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	13661000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4705000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4337000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13824000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13369000	usd
CY2022Q3	mots	Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	34000	usd
CY2021Q3	mots	Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	-35000	usd
	mots	Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	-29000	usd
	mots	Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	-152000	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-237000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-237000	usd
CY2022Q3	mots	Finance Incomeexpense Net FinanceIncomeexpenseNet	-310000	usd
CY2021Q3	mots	Finance Incomeexpense Net FinanceIncomeexpenseNet	-216000	usd
	mots	Finance Incomeexpense Net FinanceIncomeexpenseNet	-1001000	usd
	mots	Finance Incomeexpense Net FinanceIncomeexpenseNet	-450000	usd
CY2021Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	5000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	5000	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	17000	usd
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-61000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-12000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4964000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4824000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14915000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14215000	usd
	mots	Deemed Dividends From Warrant Issuance DeemedDividendsFromWarrantIssuance	-6145000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4964000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4824000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14915000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20360000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.69
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.40
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.77
CY2022Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2937530	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2412059	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2763164	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2320982	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9657000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	111000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3004000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	235000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	521000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4811000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	8606000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3972000	usd
CY2022Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	55000	usd
CY2022Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	45000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	461000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5140000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1324000	usd
CY2022Q3	mots	Stock Issued During Period Fractional Shares Settled In Cash Pursuant To Reverse Stock Split Value StockIssuedDuringPeriodFractionalSharesSettledInCashPursuantToReverseStockSplitValue	-11000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	441000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4964000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	762000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11290000	usd
CY2021Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	366000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11593000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	272000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	919000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-4649000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	19425000	usd
CY2021Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	74000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1826000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	19000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	53000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1010000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-4742000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	17591000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	165000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	848000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4824000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	13780000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14915000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14215000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	381000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	318000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	195000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	32000	usd
	mots	Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation LossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	-29000	usd
	mots	Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation LossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	-152000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1423000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2777000	usd
	mots	Issuance Of Common Stock For Board Of Directors Compensation IssuanceOfCommonStockForBoardOfDirectorsCompensation	177000	usd
	mots	Issuance Of Common Stock For Board Of Directors Compensation IssuanceOfCommonStockForBoardOfDirectorsCompensation	174000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	53000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-237000	usd
	mots	Impairment Of Inventory ImpairmentOfInventory	159000	usd
	mots	Impairment Of Inventory ImpairmentOfInventory	186000	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	46000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	253000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	152000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	52000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	146000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	843000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-48000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	167000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	97000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	79000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	38000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-255000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-163000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	61000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-51000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13429000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10505000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	215000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	425000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-215000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-425000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4544000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1900000	usd
	mots	Fractional Shares Paid In Cash Pursuant To Reverse Stock Split FractionalSharesPaidInCashPursuantToReverseStockSplit	11000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	11959000	usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	9000000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	8220000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	437000	usd
	mots	Equity Financing Fees EquityFinancingFees	-158000	usd
	mots	Equity Financing Fees EquityFinancingFees	-439000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4375000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13763000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9269000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2833000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22563000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20819000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13294000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23652000	usd
	us-gaap	Interest Paid Net InterestPaidNet	779000	usd
	us-gaap	Interest Paid Net InterestPaidNet	443000	usd
	us-gaap	Stock Issued1 StockIssued1	56000	usd
	mots	Common Stock Issued For Prepaid Board Of Directors Compensation CommonStockIssuedForPrepaidBoardOfDirectorsCompensation	58000	usd
	mots	Common Stock Issued For Prepaid Board Of Directors Compensation CommonStockIssuedForPrepaidBoardOfDirectorsCompensation	61000	usd
	mots	Reclassification Of Inventory To Fixed Assets ReclassificationOfInventoryToFixedAssets	163000	usd
	mots	Reclassification Of Inventory To Fixed Assets ReclassificationOfInventoryToFixedAssets	56000	usd
	mots	Reclassification Of Prepaid Expenses To Fixed Assets ReclassificationOfPrepaidExpensesToFixedAssets	4000	usd
	mots	Reclassification Of Prepaid Expenses To Fixed Assets ReclassificationOfPrepaidExpensesToFixedAssets	75000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	12000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	22000	usd
	mots	Financing Costs Included In Accounts Payable And Accrued Expenses FinancingCostsIncludedInAccountsPayableAndAccruedExpenses	13000	usd
	mots	Warrants Issued Related To Convertible Note And Longterm Debt Recorded As Debt Discount WarrantsIssuedRelatedToConvertibleNoteAndLongtermDebtRecordedAsDebtDiscount	165000	usd
	mots	Accrued End Of Loan Payment Recorded As Debt Discount AccruedEndOfLoanPaymentRecordedAsDebtDiscount	88000	usd
	mots	Operating Lease Liabilities Arising From Obtaining Rightofuse Assets OperatingLeaseLiabilitiesArisingFromObtainingRightofuseAssets	3000	usd
	mots	Operating Lease Liabilities Arising From Obtaining Rightofuse Assets OperatingLeaseLiabilitiesArisingFromObtainingRightofuseAssets	135000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_805_eus-gaap--NatureOfOperations_zv461gN0HvO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – <span id="xdx_82B_zOTjAnotYSjl">Description of Business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motus GI Holdings, Inc. (the “Company”) was incorporated in Delaware, U.S.A. in September 2016. The Company and its subsidiaries, Motus GI Technologies, Ltd. and Motus GI, LLC, are collectively referred to as “Motus GI” or the “Company”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the “FDA”) to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (“GI”) endoscopy procedures. The Pure-Vu System has received a CE Mark in the EU for use in colonoscopy. The Pure-Vu System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Through irrigation and evacuation of debris, the Pure-Vu System is designed to provide better-quality exams. The Company received 510(k) clearance in February 2022 from the FDA for its Pure-Vu EVS System and recently commenced commercialization of this product.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13429000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14915000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13294000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zKRttKhtBZS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zQHSQ3tJvTDg">Use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	mots	Deemed Dividend Warrants DeemedDividendWarrants	0	usd
	mots	Deemed Dividend Warrants DeemedDividendWarrants	6145000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	186000	usd
	us-gaap	Servicing Liability At Fair Value Description Of Other Changes In Fair Value ServicingLiabilityAtFairValueDescriptionOfOtherChangesInFairValue	The Company recalculated the fair value of the liability by applying a +/- 2% change to the input variable in the discounted cash flow model; the discount rate. A 2% decrease in the discount rate would increase the liability by $130 and a 2% increase in the discount rate would decrease the liability by $119
CY2022Q3	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
	us-gaap	Inventory Write Down InventoryWriteDown	159000	usd
CY2021Q3	us-gaap	Inventory Write Down InventoryWriteDown	186000	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	194000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	569000	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	120000	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	745000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	292000	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	45000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	365000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	1014000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	496000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3159000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2818000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1764000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1390000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1395000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1428000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	128000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	381000	usd
CY2022Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	10000	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	46000	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	118000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	318000	usd
	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	Certain operating leases include escalation clauses and some of which may include options to extend the leases for up to 3 years
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	16000	usd
CY2021Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	36000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	78000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	usd
CY2022Q3	us-gaap	Variable Lease Cost VariableLeaseCost	30000	usd
CY2021Q3	us-gaap	Variable Lease Cost VariableLeaseCost	30000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	90000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	90000	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	46000	usd
CY2021Q3	us-gaap	Lease Cost LeaseCost	66000	usd
	us-gaap	Lease Cost LeaseCost	168000	usd
	us-gaap	Lease Cost LeaseCost	190000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	471000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	687000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	248000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	307000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	220000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	385000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	468000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	692000	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y10M24D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y5M26D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0746	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0766	pure
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	46000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	168000	usd
CY2022Q3	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	66000	usd
	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	173000	usd
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	66000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	190000	usd
CY2021Q3	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	47000	usd
	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	141000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	803000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	195000	usd
	us-gaap	Interest Expense InterestExpense	998000	usd
CY2022Q3	us-gaap	Interest Expense Other InterestExpenseOther	268000	usd
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	70000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	338000	usd
CY2011	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	1332000	usd
CY2022Q3	mots	London Interbank Offered Rate LondonInterbankOfferedRate	1426000	usd
CY2021Q4	mots	London Interbank Offered Rate LondonInterbankOfferedRate	1419000	usd
	mots	Royalties Percentage RoyaltiesPercentage	0.04	pure
	mots	Net Sales Percentage NetSalesPercentage	0.03	pure
	mots	Licensing Percentage LicensingPercentage	0.05	pure
	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	30000000	usd
	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	30000000	usd
CY2022Q3	mots	Contingent Royalty Obligation Non Current ContingentRoyaltyObligationNonCurrent	1789000	usd
CY2021Q4	mots	Contingent Royalty Obligation Non Current ContingentRoyaltyObligationNonCurrent	1760000	usd
CY2022Q3	mots	Loss On Change In Fair Value Of Contingent Royalty Obligation LossOnChangeInFairValueOfContingentRoyaltyObligation	34000	usd
	mots	Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation LossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	-29000	usd
CY2021Q3	mots	Loss On Change In Fair Value Of Contingent Royalty Obligation LossOnChangeInFairValueOfContingentRoyaltyObligation	35000	usd
	mots	Loss On Change In Fair Value Of Contingent Royalty Obligation LossOnChangeInFairValueOfContingentRoyaltyObligation	152000	usd
	us-gaap	Manufacturing Costs ManufacturingCosts	211000	usd
	us-gaap	Severance Costs1 SeveranceCosts1	1428000	usd
CY2022Q3	mots	License Fees LicenseFees	66000	usd
	mots	License Fees LicenseFees	173000	usd
CY2021Q3	mots	License Fees LicenseFees	47000	usd
	mots	License Fees LicenseFees	141000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	441000	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	848000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1423000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2777000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	26	shares

Files In Submission

Name	View Source	Status
0001493152-22-032096-index-headers.html	Edgar Link	pending
0001493152-22-032096-index.html	Edgar Link	pending
0001493152-22-032096.txt	Edgar Link	pending
0001493152-22-032096-xbrl.zip	Edgar Link	pending
ex3-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mots-20220930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
mots-20220930_cal.xml	Edgar Link	unprocessable
mots-20220930_def.xml	Edgar Link	unprocessable
mots-20220930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mots-20220930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOTS
Motus GI Holdings Inc Stock $mots

2022 Q4 Form 10-Q Financial Statement

#000149315222032096 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOTS Motus GI Holdings Inc Stock $mots

2022 Q4 Form 10-Q Financial Statement

#000149315222032096 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOTS
Motus GI Holdings Inc Stock $mots